<div id="readability-page-1"><div><p>AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list that show how AI can support solid business models instead of speculative stories.</p> <h2>Cosmo (SWX:COPN)</h2> <p><strong>Overview:</strong> Cosmo is a Dublin based life sciences company that develops and manufactures gastroenterology, dermatology and health tech products, including GI Genius, an AI assisted endoscopy system for detecting colorectal lesions in real time, and Winlevi, a prescription acne treatment, alongside a broader portfolio for ulcerative colitis, bile acid diarrhoea and male pattern hair loss.</p> <p><strong>Operations:</strong> Cosmo currently generates all of its reported €104.2 million revenue from its Pharmaceuticals segment.</p> <p><strong>Market Cap:</strong> CHF1.20b</p> <p>Cosmo combines profitable AI tools used in hospital settings with prescription dermatology products that already have commercial traction, while also working on a late stage pipeline for male pattern hair loss that management describes as a first new mechanism in 30 years. Recent figures show strong project based contributions from GI Genius and Winlevi, a swing from operating loss to operating profit, and a larger cash position with no debt. However, the market reacted to its 2025 guidance with a sharp share price correction, and some analysts still see upside based on their target prices and fair value estimates. For investors, the mix of AI enabled medical devices, recurring royalty revenue and a deep pipeline sits alongside risks related to partner deals, competition, and future trial and regulatory outcomes.</p> <p>Profits, cash and no debt give Cosmo’s AI and dermatology mix a very different profile to many AI stocks, but the real twist may lie in the 2 key rewards and 2 important warning signs (1 is major!)</p>  <h2>Synopsys (SNPS)</h2> <p><strong>Overview:</strong> Synopsys supplies the software, chip design IP and AI driven tools that chipmakers and electronics companies use to design, verify and test complex semiconductors and systems, from CPUs and automotive chips to aerospace and industrial hardware.</p> <p><strong>Operations:</strong> Synopsys generates about US$6.3b from Design Automation and US$1.7b from Design IP, with revenue spread across the United States, Europe, Asia and other regions.</p> <p><strong>Market Cap:</strong> US$97.6b</p> <p>Synopsys sits at the heart of the AI hardware build out, supplying essential design software, IP and simulation tools that customers rely on for next generation chips, digital twins and multi chip systems. The planned integration of Ansys, push into SaaS and cloud delivery, and deeper partnerships with players like Arm, TSMC, NVIDIA and NASA indicate a business that touches many of the most demanding computing and aerospace projects. At the same time, a rich P/E, softer margins, export controls affecting China and higher borrowings set a high bar for execution. For investors who can accept those trade offs, the key question is whether Synopsys’ role in AI and complex chip design justifies the premium the market is already paying.</p> <p>Synopsys sits where AI demand, rich P/E and tighter export rules collide, yet many investors still treat it as a simple chip software story. Before you decide it is priced for perfection, scan the 1 key reward and 3 important warning signs</p>  <h2>SCREEN Holdings (TSE:7735)</h2> <p><strong>Overview:</strong> SCREEN Holdings is a Kyoto based manufacturer of semiconductor production equipment, especially wafer cleaning and inspection tools, alongside display, printed circuit board and graphic arts systems. It also sells AI powered search, text mining and image analysis solutions used across industrial, printing and medical applications.</p> <p><strong>Operations:</strong> SCREEN generates the bulk of its ¥584.7b segment revenue from Semiconductor Production Equipment at ¥474.2b, with smaller contributions from Graphic Arts Equipment at ¥53.5b, Display Production Equipment and Coater at ¥46.9b and PCB related equipment at ¥13.5b.</p> <p><strong>Market Cap:</strong> ¥2.31t</p> <p>SCREEN Holdings operates at the intersection of AI driven chip demand and the tools needed to produce those chips. Analysts expect earnings and revenue growth that outpaces the broader Japanese market, and the company trades on a P/E below both the industry average and some fair value estimates. The company is expanding into higher margin advanced packaging and recurring service revenue, which may support more stable profits over time. However, it still faces risks from reliance on China, rising domestic rivals and a recent dip in earnings and margins. For investors evaluating profitable AI exposed equipment companies where valuation does not appear stretched, SCREEN’s mix of potential and volatility may warrant closer examination, along with its funding structure and earnings track record.</p> <p>SCREEN’s mix of AI linked chip tools and a P/E below peers has many investors focusing on the headline story while missing what sits inside the 3 key rewards and 1 important warning sign</p>  <p>The three stocks in this article are just the starting point, and the full Profitable AI Stocks screener surfaces 59 more companies where AI is already tied to real earnings stories, not just ambitious roadmaps, through the Profitable AI Stocks screener. You can identify and analyze the specific catalysts, cash flows and narratives that matter to you by using Simply Wall St to filter this universe of AI earners into a shortlist of ideas that best fit your portfolio.</p> <h2>Take Control of Your Investment Journey</h2> <p> If Cosmo or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.             Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.             Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.             By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.         </p> <h2>Seeking Fresh Alternatives Before They Fly?</h2> <p>Fresh ideas move fast, and the best setups can be caught only while they are still under the radar for now. Do not wait for momentum to peak; act now.</p> <ul> <li>Hunt for underappreciated quality by scanning the 545 high quality undiscovered gems that pair solid fundamentals with stories many investors have not fully priced in yet.</li> <li>Target resilient cash generators using the curated 303 resilient stocks with low risk scores to spot businesses where lower risk scores back up the potential for steadier compounding.</li> <li>Ride structural trends in automation with the hand picked 32 robotics and automation stocks highlighting companies building the hardware and software behind factories, warehouses and next generation production lines.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data         and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your         financial situation. We aim to bring you long-term focused analysis driven by fundamental data.         Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.         Simply Wall St has no position in any stocks mentioned.</em></p></div></div>

SNPX

SNPS

SOXX

SOXL

<p>The article discusses three profitable AI stocks: Cosmo, Synopsys, and SCREEN Holdings. Cosmo, a Dublin-based life sciences company, focuses on AI-assisted medical devices and has shown a shift from operating loss to profit, with no debt. Synopsys provides essential design software for chipmakers, facing challenges like high P/E ratios and export controls. SCREEN Holdings manufactures semiconductor production equipment and is expected to grow faster than the Japanese market, but faces risks from competition and reliance on China. Each company presents unique opportunities and risks for investors in the AI sector.</p>

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse